Robert Ingram, pillar of Triangle pharma industry, dies


Robert Ingram leaves behind a legacy as a foundational leader in the Triangle's thriving pharmaceutical and biotech industries.

Previous Bluebird stock slides as company delays sickle-cell drug
Next Migraine drug maker seeks FDA approval and a partner as it cuts jobs